NIFE-trial: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) or gemcitabine plus cisplatin in advanced biliary-tract cancer: An open label, randomized, multicenter phase II trial of the AIO
Keyword(s):
Phase Ii
◽
2003 ◽
Vol 26
(2)
◽
pp. 151-154
◽